000950 重药控股
已收盘 05-14 15:00:00
资讯
新帖
简况
异动快报：重药控股（000950）5月12日10点12分触及涨停板
证券之星 · 05-12 10:21
异动快报：重药控股（000950）5月12日10点12分触及涨停板
股市必读：重药控股（000950）5月7日披露最新机构调研信息
证券之星 · 05-08
股市必读：重药控股（000950）5月7日披露最新机构调研信息
重药控股（000950）披露回购股份进展公告，5月6日股价上涨1.21%
证券之星 · 05-06
重药控股（000950）披露回购股份进展公告，5月6日股价上涨1.21%
重药控股最新公告：参股子公司硝普钠注射液获国家药监局注册批准
证券之星 · 05-06
重药控股最新公告：参股子公司硝普钠注射液获国家药监局注册批准
重药控股：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致
证券之星 · 04-29
重药控股：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致
重药控股：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致
证券之星 · 04-28
重药控股：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致
30余家药企一季报出炉：有人狂赚有人亏 行业分化加剧
21世纪经济报道 · 04-27
30余家药企一季报出炉：有人狂赚有人亏 行业分化加剧
股市必读：重药控股年报 - 第四季度单季净利润同比增长129.30%
证券之星 · 04-27
股市必读：重药控股年报 - 第四季度单季净利润同比增长129.30%
重药控股（000950）披露2025年度涉及财务公司关联交易的存款、贷款等金融业务专项说明，4月24日股价下跌2.97%
证券之星 · 04-24
重药控股（000950）披露2025年度涉及财务公司关联交易的存款、贷款等金融业务专项说明，4月24日股价下跌2.97%
重药控股(000950.SZ)发布一季度业绩，归母净利润1.71亿元，同比增长36.33%
智通财经 · 04-24
重药控股(000950.SZ)发布一季度业绩，归母净利润1.71亿元，同比增长36.33%
4月10日重药控股（000950）龙虎榜数据：机构净卖出1.29亿元（3日），北向资金净卖出789.68万元（3日）
证券之星 · 04-10
4月10日重药控股（000950）龙虎榜数据：机构净卖出1.29亿元（3日），北向资金净卖出789.68万元（3日）
重药控股：公司按照《企业会计准则》相关规定对联营企业进行相应的会计处理
证券之星 · 04-08
重药控股：公司按照《企业会计准则》相关规定对联营企业进行相应的会计处理
重药控股（000950）披露回购股份进展公告，4月2日股价上涨10.0%
证券之星 · 04-02
重药控股（000950）披露回购股份进展公告，4月2日股价上涨10.0%
BD+业绩双重炸裂，创新药多股涨停，黄金窗口期来了？
格隆汇 · 04-02
BD+业绩双重炸裂，创新药多股涨停，黄金窗口期来了？
重药控股：目前公司没有与药石科技合作
证券之星 · 04-02
重药控股：目前公司没有与药石科技合作
重药控股（000950）披露2026年第二次临时股东会决议公告，3月27日股价上涨2.19%
证券之星 · 03-27
重药控股（000950）披露2026年第二次临时股东会决议公告，3月27日股价上涨2.19%
重药控股（000950）披露召开2026年第二次临时股东会的提示性公告，3月23日股价下跌4.93%
证券之星 · 03-23
重药控股（000950）披露召开2026年第二次临时股东会的提示性公告，3月23日股价下跌4.93%
股市必读：重药控股（000950）3月13日董秘有最新回复
证券之星 · 03-16
股市必读：重药控股（000950）3月13日董秘有最新回复
重药控股：公司3月11日披露的《关于2026年度融资计划的公告》（公告编号
证券之星 · 03-13
重药控股：公司3月11日披露的《关于2026年度融资计划的公告》（公告编号
重药控股（000950）披露召开2026年第二次临时股东会的通知，3月10日股价上涨0.35%
证券之星 · 03-10
重药控股（000950）披露召开2026年第二次临时股东会的通知，3月10日股价上涨0.35%
暂无数据
公司概况
公司名称：
重药控股股份有限公司
所属行业：
批发业
上市日期：
1999-09-16
主营业务：
重药控股股份有限公司的主营业务是医药商业、仓储物流、医药工业和研发等业务。公司的主要产品是药品、医疗器械、中药饮片、保健产品。
发行价格：
4.63
{"stockData":{"symbol":"000950","market":"SZ","secType":"STK","nameCN":"重药控股","latestPrice":6.75,"timestamp":1778742210000,"preClose":6.72,"halted":0,"volume":110598049,"delay":0,"changeRate":0.0045,"floatShares":1728000000,"shares":1728000000,"eps":0.2501,"marketStatus":"已收盘","change":0.03,"latestTime":"05-14 15:00:00","open":6.63,"high":7,"low":6.63,"amount":753000000,"amplitude":0.0551,"askPrice":6.76,"askSize":931,"bidPrice":6.75,"bidSize":1367,"shortable":0,"etf":0,"ttmEps":0.2501,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778808600000},"marketStatusCode":5,"adr":0,"adjPreClose":6.72,"symbolType":"stock","openAndCloseTimeList":[[1778722200000,1778729400000],[1778734800000,1778742000000]],"highLimit":7.39,"lowLimit":6.05,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1728184696,"isCdr":false,"pbRate":0.99,"roa":"--","peRate":26.989204,"roe":"1.47%","epsLYR":0.22,"committee":-0.495598,"marketValue":11665000000,"turnoverRate":0.064,"status":0,"floatMarketCap":11665000000},"requestUrl":"/m/hq/s/000950/tweets","defaultTab":"tweets","newsList":[{"id":"2634257725","title":"异动快报：重药控股（000950）5月12日10点12分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2634257725","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634257725?lang=zh_cn&edition=full","pubTime":"2026-05-12 10:21","pubTimestamp":1778552463,"startTime":"0","endTime":"0","summary":"证券之星5月12日盘中消息，10点12分重药控股（000950）触及涨停板。其所属行业医药商业目前下跌。领涨股为重药控股。该股为重庆国企改革，医疗耗材供应链SPD，国企改革概念热股，当日重庆国企改革概念上涨0.39%。5月11日的资金流向数据方面，主力资金净流入3452.12万元，占总成交额6.84%，游资资金净流出563.98万元，占总成交额1.12%，散户资金净流出2888.14万元，占总成交额5.72%。近5日资金流向一览见下表：重药控股主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200012086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633712762","title":"股市必读：重药控股（000950）5月7日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2633712762","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633712762?lang=zh_cn&edition=full","pubTime":"2026-05-08 01:28","pubTimestamp":1778174892,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，重药控股报收于5.87元，上涨0.0%，换手率1.77%，成交量30.65万手，成交额1.8亿元。机构调研要点公司于2025年12月11日披露药友制药与上海复星医药产业发展有限公司及辉瑞签订许可协议，目前协议正常履行中。关于参股子公司与辉瑞合作的减肥药项目，公司将依规履行信息披露义务。公司公告汇总重药控股于2025年7月审议通过股份回购方案，拟使用8000万元至1亿元资金回购股份用于减资，价格不超过6.6元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800001515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633132688","title":"重药控股（000950）披露回购股份进展公告，5月6日股价上涨1.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633132688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633132688?lang=zh_cn&edition=full","pubTime":"2026-05-06 22:54","pubTimestamp":1778079260,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，重药控股报收于5.87元，较前一交易日上涨1.21%，最新总市值为101.44亿元。该股当日开盘5.81元，最高5.89元，最低5.81元，成交额达1.7亿元，换手率为1.68%。近日，重药控股发布《关于回购股份进展的公告》。公告显示，公司于2025年7月10日和7月28日分别召开董事会及临时股东会，审议通过回购公司股份的议案。回购进展符合相关法规及公司方案要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600040225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633180424","title":"重药控股最新公告：参股子公司硝普钠注射液获国家药监局注册批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2633180424","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633180424?lang=zh_cn&edition=full","pubTime":"2026-05-06 19:49","pubTimestamp":1778068191,"startTime":"0","endTime":"0","summary":"重药控股(000950.SZ)公告称，公司参股子公司重庆药友制药的硝普钠注射液获国家药品监督管理局注册批准，适应症包括高血压急症和急性心力衰竭。该药品2025年在中国境内销售额约1.12亿元，将进一步丰富产品线，但销售情况受多重因素影响，存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600035173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631555283","title":"重药控股：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致","url":"https://stock-news.laohu8.com/highlight/detail?id=2631555283","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631555283?lang=zh_cn&edition=full","pubTime":"2026-04-29 11:33","pubTimestamp":1777433583,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)04月28日在投资者关系平台上答复投资者关心的问题。投资者提问：2025年，公司高管薪酬总额增长率远超业绩增长率，请问公司的薪酬制度合理吗，是否损害了中小股东利益？重药控股回复：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900037357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630442643","title":"重药控股：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致","url":"https://stock-news.laohu8.com/highlight/detail?id=2630442643","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630442643?lang=zh_cn&edition=full","pubTime":"2026-04-28 09:03","pubTimestamp":1777338186,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)04月27日在投资者关系平台上答复投资者关心的问题。投资者提问：2025年，公司高管薪酬总额增长率为82.87%，而营业收入增长率只有2.34%，差额较大且远超同行，请问这合理吗？重药控股回复：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800027836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630395435","title":"30余家药企一季报出炉：有人狂赚有人亏 行业分化加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=2630395435","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630395435?lang=zh_cn&edition=full","pubTime":"2026-04-27 19:29","pubTimestamp":1777289340,"startTime":"0","endTime":"0","summary":"近日，A股医药板块迎来一季度财报密集披露期，包括阳光诺和、华东医药、重药控股、圣诺生物、我武生物、一品红、丽珠集团、浙江医药、济川药业、科源制药、千红制药等在内的超30家药企集中交出第一季度成绩单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604273720459429.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604273720459429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0191","BK0132","BK0071","300723","BK0216","002550","688117","BK0175","000963","BK0250","000950","301281","688621","BK1574","06978","BK0183","BK0209","LU1969619763.USD","BK0028","BK1161","LU2328871848.SGD","BK0188","600216","BK0196","BK0187","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630351783","title":"股市必读：重药控股年报 - 第四季度单季净利润同比增长129.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630351783","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630351783?lang=zh_cn&edition=full","pubTime":"2026-04-27 02:11","pubTimestamp":1777227069,"startTime":"0","endTime":"0","summary":"股本股东变化股东户数变动截至2026年3月31日公司股东户数为5.21万户，较12月31日减少4219.0户，减幅为7.49%。2025年度内部控制审计报告致同会计师事务所对重药控股股份有限公司2025年12月31日的财务报告内部控制有效性进行了审计。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700005062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629677812","title":"重药控股（000950）披露2025年度涉及财务公司关联交易的存款、贷款等金融业务专项说明，4月24日股价下跌2.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629677812","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629677812?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:45","pubTimestamp":1777023922,"startTime":"0","endTime":"0","summary":"重药控股于近日披露《关于重药控股股份有限公司涉及财务公司关联交易的存款、贷款等金融业务的专项说明》。公告显示，致同会计师事务所对重药控股股份有限公司2025年度通过重庆化医控股集团财务有限公司和通用技术集团财务有限责任公司开展的存款、贷款等金融业务进行了专项说明。截至2025年末，公司在财务公司存放存款余额为4,594,116,719.28元，向通用技术集团财务有限责任公司贷款余额为3,840,975,981.02元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400053898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629851880","title":"重药控股(000950.SZ)发布一季度业绩，归母净利润1.71亿元，同比增长36.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629851880","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629851880?lang=zh_cn&edition=full","pubTime":"2026-04-24 00:47","pubTimestamp":1776962832,"startTime":"0","endTime":"0","summary":"智通财经APP讯，重药控股(000950.SZ)发布2026年第一季度报告，第一季度，公司实现营业收入204.32亿元，同比下降0.87%。归属于上市公司股东的净利润1.71亿元，同比增长36.33%。归属于上市公司股东的扣除非经常性损益的净利润1.66亿元，同比增长36.35%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"重药控股(000950.SZ)发布一季度业绩，归母净利润1.71亿元，同比增长36.33%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626195398","title":"4月10日重药控股（000950）龙虎榜数据：机构净卖出1.29亿元（3日），北向资金净卖出789.68万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2626195398","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626195398?lang=zh_cn&edition=full","pubTime":"2026-04-10 17:14","pubTimestamp":1775812458,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年4月10日公布的交易公开信息显示，重药控股因连续三个交易日内，跌幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年4月10日收盘，重药控股报收于6.08元，下跌1.94%，换手率7.18%，成交量124.08万手，成交额7.47亿元。从龙虎榜公布的三日买卖数据来看，机构合计净卖出1.29亿元，北向资金合计净卖出789.68万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000029216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625978919","title":"重药控股：公司按照《企业会计准则》相关规定对联营企业进行相应的会计处理","url":"https://stock-news.laohu8.com/highlight/detail?id=2625978919","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625978919?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:30","pubTimestamp":1775637024,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股04月08日在投资者关系平台上答复投资者关心的问题。投资者提问：公司1.4号公众号说控股子公司药友制药的口服小分子胰高血糖素样肽-1受体激动剂已收到辉瑞支付的首付款15,000万美元，请问是否会计入公司一季报重药控股回复：公司按照《企业会计准则》相关规定对联营企业进行相应的会计处理，对于参股子公司重庆药友制药实现的利润会根据持股比例按照权益法确认相应的投资收益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800025082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624502775","title":"重药控股（000950）披露回购股份进展公告，4月2日股价上涨10.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624502775","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624502775?lang=zh_cn&edition=full","pubTime":"2026-04-02 22:05","pubTimestamp":1775138720,"startTime":"0","endTime":"0","summary":"截至2026年4月2日收盘，重药控股报收于6.49元，较前一交易日上涨10.0%，最新总市值为112.16亿元。公司于近日披露《关于回购股份进展的公告》。公告显示，重药控股股份有限公司于2025年7月10日和7月28日审议通过回购股份议案，拟使用自有资金及专项贷款通过集中竞价方式回购公司A股股份，用于减少注册资本。回购进展符合相关法规及公司方案要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200041757.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624157850","title":"BD+业绩双重炸裂，创新药多股涨停，黄金窗口期来了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2624157850","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624157850?lang=zh_cn&edition=full","pubTime":"2026-04-02 14:03","pubTimestamp":1775109822,"startTime":"0","endTime":"0","summary":"进入收获期","market":"fut","thumbnail":"https://img3.gelonghui.com/a401d-e32ea773-2592-402d-a56d-8ff49dc1dd78.jpg?guru_height=718&guru_width=1280&guru_size=112216","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a401d-e32ea773-2592-402d-a56d-8ff49dc1dd78.jpg?guru_height=718&guru_width=1280&guru_size=112216"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4283048","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["GLL","600594","BK4585","BTGD","XME","000788","IAUM","518880","CEF","159934","IAU","PALL","600488","300086","GDXJ","GDXU","DGP","159992","DZZ","159831","JNUG","SGOL","AAAU","SGUmain","06978","000950","GDX","OUNZ","PHYS","NUGT","02186","JDST","USG","QOmain","DUST","GLDM","GLTR","BK1191","GDXD","GCmain","IAUI","603222","SGCmain","1OZmain","BK0188","GLD","UGL","MGCmain","02162","GDXY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624524964","title":"重药控股：目前公司没有与药石科技合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2624524964","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624524964?lang=zh_cn&edition=full","pubTime":"2026-04-02 11:34","pubTimestamp":1775100881,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股04月01日在投资者关系平台上答复投资者关心的问题。投资者提问：1.药石科技在分子砌块、连续流工艺、ADC/TPD关键中间体等领域具备国内独一档的技术壁垒，也是很多创新药公司早期研发和CMC开发的重要合作伙伴。未来是否有计划在早期化合物发现、工艺开发或商业化生产层面开展合作？","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200015075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0071","000950","BK0250","300725"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622425748","title":"重药控股（000950）披露2026年第二次临时股东会决议公告，3月27日股价上涨2.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622425748","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622425748?lang=zh_cn&edition=full","pubTime":"2026-03-27 17:24","pubTimestamp":1774603498,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，重药控股报收于5.59元，较前一交易日上涨2.19%，最新总市值为96.61亿元。该股当日开盘5.45元，最高5.61元，最低5.42元，成交额达9886.76万元，换手率为1.03%。重药控股于近日披露《2026年第二次临时股东会决议公告》。各项议案均获通过，表决结果合法有效。出席股东代表股份占公司有表决权股份总数的59.8690%，其中网络投票股东343人。北京市竞天公诚律师事务所对本次股东会出具法律意见书，认为会议召集、召开程序及表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700036417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621704900","title":"重药控股（000950）披露召开2026年第二次临时股东会的提示性公告，3月23日股价下跌4.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621704900","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621704900?lang=zh_cn&edition=full","pubTime":"2026-03-23 22:22","pubTimestamp":1774275737,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，重药控股报收于5.21元，较前一交易日下跌4.93%，最新总市值为90.04亿元。该股当日开盘5.44元，最高5.44元，最低5.18元，成交额达1.37亿元，换手率为1.5%。近日，重药控股股份有限公司发布《关于召开2026年第二次临时股东会的提示性公告》。公告显示，公司将于2026年3月26日召开2026年第二次临时股东会，会议采用现场与网络投票相结合方式，股权登记日为2026年3月23日。登记时间为2026年3月24日至25日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300039807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619100174","title":"股市必读：重药控股（000950）3月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2619100174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619100174?lang=zh_cn&edition=full","pubTime":"2026-03-16 02:20","pubTimestamp":1773598825,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，重药控股报收于5.78元，上涨0.35%，换手率1.02%，成交量17.58万手，成交额1.02亿元。董秘最新回复投资者： 3月11日公告“关于2026年度融资计划的公告”的金额2049000万，是包含当日发布其他所有公告融资额？交易信息汇总资金流向3月13日主力资金净流入725.2万元；游资资金净流出476.28万元；散户资金净流出248.92万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600000884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000950","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619167076","title":"重药控股：公司3月11日披露的《关于2026年度融资计划的公告》（公告编号","url":"https://stock-news.laohu8.com/highlight/detail?id=2619167076","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619167076?lang=zh_cn&edition=full","pubTime":"2026-03-13 17:00","pubTimestamp":1773392436,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股03月13日在投资者关系平台上答复投资者关心的问题。投资者提问：3月11日公告“关于2026年度融资计划的公告”的金额2049000万，是包含当日发布其他所有公告融资额？","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300028400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618903951","title":"重药控股（000950）披露召开2026年第二次临时股东会的通知，3月10日股价上涨0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618903951","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618903951?lang=zh_cn&edition=full","pubTime":"2026-03-10 22:39","pubTimestamp":1773153556,"startTime":"0","endTime":"0","summary":"截至2026年3月10日收盘，重药控股报收于5.77元，较前一交易日上涨0.35%，最新总市值为99.72亿元。该股当日开盘5.76元，最高5.81元，最低5.72元，成交额达8662.8万元，换手率为0.87%。近日，重药控股股份有限公司披露《关于召开2026年第二次临时股东会的通知》。公告显示，公司将于2026年3月26日召开2026年第二次临时股东会，会议由董事会召集，现场会议时间为当日14:30，网络投票时间为同日上午9:15至下午15:00。股权登记日为2026年3月23日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000038612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778769510705,"stockEarnings":[{"period":"1week","weight":0.1448},{"period":"1month","weight":0.1429},{"period":"3month","weight":0.1527},{"period":"6month","weight":0.2037},{"period":"1year","weight":0.3807},{"period":"ytd","weight":0.1602}],"compareEarnings":[{"period":"1week","weight":0.0198},{"period":"1month","weight":0.0637},{"period":"3month","weight":0.0263},{"period":"6month","weight":0.0632},{"period":"1year","weight":0.2571},{"period":"ytd","weight":0.069}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重药控股股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"52072人(较上一季度减少7.49%)","perCapita":"33188股","listingDate":"1999-09-16","address":"重庆市两江新区金石大道303号","registeredCapital":"172818万元","survey":" 重药控股股份有限公司的主营业务是医药商业、仓储物流、医药工业和研发等业务。公司的主要产品是药品、医疗器械、中药饮片、保健产品。","listedPrice":4.63},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"重药控股(000950)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供重药控股(000950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"重药控股,000950,重药控股股票,重药控股股票老虎,重药控股股票老虎国际,重药控股行情,重药控股股票行情,重药控股股价,重药控股股市,重药控股股票价格,重药控股股票交易,重药控股股票购买,重药控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"重药控股(000950)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供重药控股(000950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}